Discovery of 3-[2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide (AP24534), a potent, orally active pan-inhibitor of breakpoint cluster region-abelson (BCR-ABL) kinase includ (Q34118184)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Discovery of 3-[2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide (AP24534), a potent, orally active pan-inhibitor of breakpoint cluster region-abelson (BCR-ABL) kinase includ
scientific article

    Statements

    Discovery of 3-[2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide (AP24534), a potent, orally active pan-inhibitor of breakpoint cluster region-abelson (BCR-ABL) kinase includ (English)
    Wei-Sheng Huang
    Chester A Metcalf
    Raji Sundaramoorthi
    R Mathew Thomas
    Xiaotian Zhu
    Shuangying Liu
    Ingrid Chen
    Geetha Banda
    Scott P Lentini
    Sasmita Das
    Scott Wardwell
    Joseph T Snodgrass
    Marc I Broudy
    Karin Russian
    Tianjun Zhou
    Lois Commodore
    Narayana I Narasimhan
    Qurish K Mohemmad
    John Iuliucci
    Victor M Rivera
    David C Dalgarno
    Tomi K Sawyer
    Tim Clackson
    William C Shakespeare
    4701-4719

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit